These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9310876)

  • 1. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects.
    Heijl L; Heden G; Svärdström G; Ostgren A
    J Clin Periodontol; 1997 Sep; 24(9 Pt 2):705-14. PubMed ID: 9310876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of platelet-rich fibrin vs. enamel matrix derivative in the treatment of periodontal intrabony defects: a clinical and cone beam computed tomography study.
    Gupta SJ; Jhingran R; Gupta V; Bains VK; Madan R; Rizvi I
    J Int Acad Periodontol; 2014 Jul; 16(3):86-96. PubMed ID: 25654961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical safety of enamel matrix derivative (EMDOGAIN) in the treatment of periodontal defects.
    Zetterström O; Andersson C; Eriksson L; Fredriksson A; Friskopp J; Heden G; Jansson B; Lundgren T; Nilveus R; Olsson A; Renvert S; Salonen L; Sjöström L; Winell A; Ostgren A; Gestrelius S
    J Clin Periodontol; 1997 Sep; 24(9 Pt 2):697-704. PubMed ID: 9310875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enamel matrix proteins in the treatment of intra-bony defects. A prospective 24-month clinical trial.
    Francetti L; Del Fabbro M; Basso M; Testori T; Weinstein R
    J Clin Periodontol; 2004 Jan; 31(1):52-9. PubMed ID: 15058375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects.
    Heden G; Wennström JL
    J Periodontol; 2006 Feb; 77(2):295-301. PubMed ID: 16460257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontal tissue alterations following Emdogain treatment of periodontal sites with angular bone defects. A series of case reports.
    Heden G; Wennström J; Lindhe J
    J Clin Periodontol; 1999 Dec; 26(12):855-60. PubMed ID: 10599915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enamel matrix derivative in the treatment of human intrabony osseous defects.
    Okuda K; Momose M; Miyazaki A; Murata M; Yokoyama S; Yonezawa Y; Wolff LF; Yoshie H
    J Periodontol; 2000 Dec; 71(12):1821-8. PubMed ID: 11156038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enamel matrix proteins in the treatment of deep intrabony defects.
    Cardaropoli G; Leonhardt AS
    J Periodontol; 2002 May; 73(5):501-4. PubMed ID: 12027251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Emdogain in the treatment of deep intrabony defects: 12-month clinical results. Histologic and radiographic evaluation.
    Parodi R; Liuzzo G; Patrucco P; Brunel G; Santarelli GA; Birardi V; Gasparetto B
    Int J Periodontics Restorative Dent; 2000 Dec; 20(6):584-95. PubMed ID: 11203595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects.
    Gamal AY; Mailhot JM
    J Int Acad Periodontol; 2008 Oct; 10(4):106-17. PubMed ID: 19055224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report study of 72 consecutive Emdogain-treated intrabony periodontal defects: clinical and radiographic findings after 1 year.
    Heden G
    Int J Periodontics Restorative Dent; 2000 Apr; 20(2):127-39. PubMed ID: 11203555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
    Yilmaz S; Cakar G; Yildirim B; Sculean A
    J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study.
    Francetti L; Trombelli L; Lombardo G; Guida L; Cafiero C; Roccuzzo M; Carusi G; Del Fabbro M
    Int J Periodontics Restorative Dent; 2005 Oct; 25(5):461-73. PubMed ID: 16250568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EDTA gel root conditioning: lack of effect on clinical and radiographic outcomes of intrabony defect treatment with enamel matrix derivative.
    Parashis AO; Tsiklakis K; Tatakis DN
    J Periodontol; 2006 Jan; 77(1):103-10. PubMed ID: 16579710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of periodontal defects with enamel matrix derivative: clinical evaluation at early healing stages.
    Saito A; Hayakawa H; Ota K; Fujinami K; Nikaido M; Makiishi T
    Bull Tokyo Dent Coll; 2010; 51(2):85-93. PubMed ID: 20689239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative (Emdogain).
    Sculean A; Chiantella GC; Windisch P; Donos N
    Int J Periodontics Restorative Dent; 2000 Aug; 20(4):374-81. PubMed ID: 11203577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of infrabony defects treated with enamel matrix derivative versus guided tissue regeneration with a nonresorbable membrane.
    Silvestri M; Sartori S; Rasperini G; Ricci G; Rota C; Cattaneo V
    J Clin Periodontol; 2003 May; 30(5):386-93. PubMed ID: 12716329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects.
    Bokan I; Bill JS; Schlagenhauf U
    J Clin Periodontol; 2006 Dec; 33(12):885-93. PubMed ID: 17092241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.